Developing a manufacturing process and analyses for a recombinant protein drug.
Florin-Robertsson
Ebba
E
Senior Scientist Pharmacy, Biovitrum AB, S-11276 Stockholm.
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D004345:Drug Industry; D004768:Enterotoxins / Q000737:chemistry* / Q000276:immunology; D007140:Immunoglobulin Fab Fragments / Q000737:chemistry* / Q000276:immunology; D010449:Peptide Mapping; D011993:Recombinant Fusion Proteins / Q000737:chemistry* / Q000276:immunology; D018089:Superantigens / Q000737:chemistry* / Q000276:immunology
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D004768:Enterotoxins; D007140:Immunoglobulin Fab Fragments; D011993:Recombinant Fusion Proteins; D018089:Superantigens; C026066:enterotoxin A, Staphylococcal